SJS Investment Consulting’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Buy
1,992
+349
+21% +$40.9K 0.03% 139
2026
Q1
$198K Sell
1,643
-514
-24% -$59.3K 0.02% 153
2025
Q4
$227K Buy
2,157
+159
+8% +$14.9K 0.03% 132
2025
Q3
$168K Buy
1,998
+1,182
+145% +$97.4K 0.02% 143
2025
Q2
$64.6K Sell
816
-57
-7% -$4.53K 0.01% 163
2025
Q1
$78.4K Sell
873
-13
-1% -$1.21K 0.01% 157
2024
Q4
$88.1K Sell
886
-404
-31% -$41.6K 0.02% 147
2024
Q3
$146K Buy
1,290
+131
+11% +$15.6K 0.03% 114
2024
Q2
$143K Sell
1,159
-40
-3% -$5.15K 0.03% 102
2024
Q1
$158K Hold
1,199
0.03% 100
2023
Q4
$131K Sell
1,199
-238
-17% -$24.7K 0.03% 102
2023
Q3
$148K Buy
1,437
+189
+15% +$20.4K 0.04% 87
2023
Q2
$144K Sell
1,248
-22
-2% -$2.5K 0.04% 89
2023
Q1
$135K Buy
1,270
+42
+3% +$4.54K 0.04% 93
2022
Q4
$136K Buy
1,228
+72
+6% +$7.36K 0.04% 97
2022
Q3
$100K Buy
+1,156
New +$103K 0.03% 118
2022
Q1
$9K Buy
108
+42
+64% +$3.31K ﹤0.01% 399
2021
Q4
$5K Buy
+66
New +$5.26K ﹤0.01% 430

Other funds holding MRK

SJS Investment Consulting's MRK Position: Q2 2026 in Review

SJS Investment Consulting increased its Merck (MRK) stake by 21% in Q2 2026, buying an estimated $40.9K and bringing the position to 1,992 shares worth $256K. The position accounts for 0.03% of the portfolio, ranked #139.

SJS Investment Consulting first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • SJS Investment Consulting held 1,992 shares of Merck worth $256K as of Q2 2026.
  • SJS Investment Consulting bought 349 Merck shares in Q2 2026, an estimated $40.9K.
  • Merck made up 0.03% of SJS Investment Consulting's portfolio in Q2 2026, its #139 holding.
  • SJS Investment Consulting first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.